Obesity is known to impair the NO pathway, which includes not only eNOS activity but also NO bioavailability and essential cofactors (Förstermann, 2010; Rashid, 2020). The gene discussed is NOS3; the disease is obesity due to melanocortin 4 receptor deficiency.